// App-Quantinova.ai

: Fibrinogen Concentrate Vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Researchers

Presenter

  • Ashok Roy

Principal Investigators

  • Nigel Sargant

  • Savita Rangarajan

  • Sue Alves

  • John Bell

  • Sophia Stanford

  • Cristina Solomon

  • Irina Kruzhkova

  • Sigurd Knaub

  • Faheez Mohamed

Medical Centers

  • Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Basingstoke Hospital, Hampshire Hospitals Hospital NHS Foundation Trust, Basingstoke, United Kingdom

  • Octapharma AG, Lachen, CHE

  • Octapharma AG, Lachen, Switzerland

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gelatinous peritoneal

Biomarkers

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Randomized

  • Prospective

  • Controlled

  • Single Center

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved